Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.

Detalles Bibliográficos
Autores principales: Alvarez-Escola, Cristina, Cárdenas-Salas, Jersy J, Pelegrina, Beatriz, Sanz-Valtierra, Angel, Lecumberri, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641480/
https://www.ncbi.nlm.nih.gov/pubmed/26576278
http://dx.doi.org/10.1002/ccr3.388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641480/
https://www.ncbi.nlm.nih.gov/pubmed/26576278
http://dx.doi.org/10.1002/ccr3.388

Ejemplares similares